Home/Filings/4/0000899243-20-008928
4//SEC Filing

SOFTBANK VISION FUND (AIV M2) L.P. 4

Accession 0000899243-20-008928

CIK 0001770787other

Filed

Mar 17, 8:00 PM ET

Accepted

Mar 18, 6:17 PM ET

Size

17.9 KB

Accession

0000899243-20-008928

Insider Transaction Report

Form 4
Period: 2019-09-16
Transactions
  • Conversion

    Class A Common Stock

    2020-02-19+3,836,2323,836,232 total(indirect: See footnote)
  • Conversion

    Class B Common Stock

    2019-09-16+3,836,2323,836,232 total(indirect: See footnote)
    Class A Common Stock (3,836,232 underlying)
  • Conversion

    Series C Convertible Preferred Stock

    2019-09-162,791,3000 total(indirect: See footnote)
    Class B Common Stock (2,791,300 underlying)
  • Conversion

    Series D Convertible Preferred Stock

    2019-09-161,044,9320 total(indirect: See footnote)
    Class B Common Stock (1,044,932 underlying)
  • Conversion

    Class B Common Stock

    2020-02-193,836,2320 total(indirect: See footnote)
    Class A Common Stock (3,836,232 underlying)
Transactions
  • Conversion

    Class A Common Stock

    2020-02-19+3,836,2323,836,232 total(indirect: See footnote)
  • Conversion

    Class B Common Stock

    2019-09-16+3,836,2323,836,232 total(indirect: See footnote)
    Class A Common Stock (3,836,232 underlying)
  • Conversion

    Series C Convertible Preferred Stock

    2019-09-162,791,3000 total(indirect: See footnote)
    Class B Common Stock (2,791,300 underlying)
  • Conversion

    Series D Convertible Preferred Stock

    2019-09-161,044,9320 total(indirect: See footnote)
    Class B Common Stock (1,044,932 underlying)
  • Conversion

    Class B Common Stock

    2020-02-193,836,2320 total(indirect: See footnote)
    Class A Common Stock (3,836,232 underlying)
Footnotes (3)
  • [F1]The Class B Common Stock is convertible at any time at the option of the holder into Class A Common Stock on a 1:1 basis and has no expiration date. Additionally, all outstanding shares of Class B Common Stock will convert automatically into Class A Common Stock upon any transfer, whether or not for value (subject to certain exceptions), and upon the occurrence of certain other events set forth in the Issuer's Amended and Restated Certificate of Incorporation.
  • [F2]The Series C Convertible Preferred Stock and the Series D Convertible Preferred Stock (the "Convertible Preferred Stock") automatically converted into Class B Common Stock on a 1:1 basis immediately prior to the completion of the Issuer's initial public offering of Class A Common Stock. There is no expiration date for the Convertible Preferred Stock.
  • [F3]Represents securities held directly by SoftBank Vision Fund (AIV M2) L.P. ("SVF"). SB Investment Advisers (UK) Limited ("SBIA UK") has been appointed as alternative investment fund manager ("AIFM") and is exclusively responsible for managing SVF in accordance with the Alternative Investment Fund Managers Directive and is authorized and regulated by the UK Financial Conduct Authority accordingly. As AIFM of SVF, SBIA UK is exclusively responsible for portfolio management and risk management. SBIA UK disclaims beneficial ownership of such shares except to the extent of its pecuniary interest therein, and the inclusion of these securities in this report shall not be deemed an admission that any reporting person is the beneficial owner of such shares for purposes of the Securities Exchange Act of 1934 or for any other purpose.

Issuer

10x Genomics, Inc.

CIK 0001770787

Entity typeother
IncorporatedDE

Related Parties

1
  • filerCIK 0001805808

Filing Metadata

Form type
4
Filed
Mar 17, 8:00 PM ET
Accepted
Mar 18, 6:17 PM ET
Size
17.9 KB